For example, studies have shown that PP2A inhibition or activation of the STING pathway increases type I IFN signaling in TAMs, leading to increased activation of macrophages and CD8+ T cells and a subsequent reduction in tumor volume in mice [129,157]. This evidence concerns the gene STING1 and neoplasm.